HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹22.53
Day range
₹21.90 - ₹22.99
Year range
₹21.90 - ₹76.10
Market cap
1.21B INR
Avg Volume
149.95K
P/E ratio
12.85
Dividend yield
-
Primary exchange
NSE
Market news
Simply Wall Street
11 minutes ago
Expand Energy Leadership Shift And Houston Move Reframe Growth Story
1.00%
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 725.42M | -1.02% |
Operating expense | 282.77M | 9.00% |
Net income | 3.05M | -94.31% |
Net profit margin | 0.42 | -94.26% |
Earnings per share | — | — |
EBITDA | 29.57M | -25.85% |
Effective tax rate | 81.05% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 388.49M | -36.17% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.38B | — |
Shares outstanding | 50.83M | — |
Price to book | 0.49 | — |
Return on assets | — | — |
Return on capital | 2.15% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 3.05M | -94.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600
